Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Wnt3 ELISA Kit (AC2859)
Cat.#: ASET-1448
Specifications
Description Human Wnt3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Wnt3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.057 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry ASET-2492 Rat ERK1 + ERK2 ELISA Kit (AC3903) Quantitative inquiry ASET-2329 Mouse Galectin 3 ELISA Kit (AC3740) Quantitative inquiry ASET-1550 Human TAS2R38 ELISA Kit (AC2961) Quantitative inquiry ASET-1946 Human Alpha B Crystallin ELISA Kit (AC3357) Quantitative inquiry ASET-2232 Rat GCLM ELISA Kit (AC3643) Quantitative inquiry ASET-1661 Mouse c-Kit ELISA Kit (AC3072) Quantitative inquiry ASET-1392 Human Semaphorin 3A ELISA Kit (AC2803) Quantitative inquiry ASET-2293 Mouse Wnt5a ELISA Kit (AC3704) Quantitative inquiry ASET-1671 Human KLC1 ELISA Kit (AC3082) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket